Research presented December 8 at the American Society of Hematology Conference in Florida, has shown that a new kind of CAR T ...
Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR ...
Measuring the lymphocytes—white blood cells that fight infection—in a patient's blood can be used to predict outcomes in ...
Sofi-cel is an investigational, potential first-in-class, allogeneic, anti-CD7 CAR-T cell therapy currently under evaluation in a pivotal trial (T-RRex) for patients with relapsed or refractory (R/R) ...
CAR-T cell therapy for people with autoimmune diseases such as lupus is in its early stages. While the therapy presents a powerful new strategy for treatment, a recent review highlights potential ...
The U.S. Food and Drug Administration advisory committee unanimously recommended the agency approve a unique “living drug” approach to treat a common form of leukemia in children and young adults, ...
Looking to build a new laboratory or expand your existing facility. Talk to your Formaspace Design Consultant about our custom lab furniture solutions, built in the USA, at our Austin, Texas, factory ...
Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback